Notably, activation of HIF‐2α will lead to impaired fatty acid β‐oxidation, decreased lipogenic gene expression, and increased lipid storage capacity, ultimately progressing to severe hepatic steatosis [15]. Here, EPAS1 is linked to fatty liver disease.